Pyrexia, commonly known as fever, is a frequently encountered symptom in clinical practice. It is a physiological response to various conditions, primarily infections, but also non-infectious diseases and drug reactions. Understanding the underlying mechanisms and management strategies is crucial for effective patient care.
The hypothalamus, acting as the body's thermostat, plays a pivotal role in fever development. Pyrogens, substances that induce fever, can be either exogenous, such as microbial toxins, or endogenous, like cytokines. These pyrogens trigger the synthesis of prostaglandin E2 (PGE2) in the hypothalamus, raising the body's set point temperature.
Initial assessment should focus on identifying the cause of the fever. History taking and physical examination are essential. Particular attention should be paid to recent travel, exposure to infectious diseases, drug history, and the presence of localizing symptoms. Investigations may include blood tests, imaging, and cultures depending on the clinical picture.
Management is generally twofold: treating the underlying cause and managing the fever itself. Antipyretics, such as paracetamol and nonsteroidal anti-inflammatory drugs (NSAIDs), can be used to reduce discomfort. However, it is important to remember that fever is a beneficial response that aids in pathogen clearance. Thus, antipyretics should not be used routinely without a clear indication.
Special populations such as infants, elderly, and immunocompromised individuals may present atypically or have a greater risk of serious underlying conditions. Therefore, a high degree of suspicion is warranted in these cases.
Pyrexia is a common but complex clinical presentation. A thorough understanding of its pathophysiology, clinical assessment, and management strategies is essential for healthcare professionals. While fever often indicates an underlying infectious process, it is crucial to consider non-infectious etiologies and tailor the management approach accordingly.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation